Effects of Perfluorohexane Sulfonate Exposure on Immune Cell Populations in Naive Mice
ImmunoHorizons · 2024
DOI: 10.4049/immunohorizons.2300049 ↗Kurz gefasst
Fachartikel in der Zeitschrift ImmunoHorizons, 2024. Verfasst von Timothy M Pierpont und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology & Immunology, Cornell University, Ithaca, NY. Hauptthemen laut MEDLINE: Fluorocarbons. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Perfluorohexane sulfonate (PFHxS) is a member of the per- and polyfluoroalkyls (PFAS) superfamily of molecules, characterized by their fluorinated carbon chains and use in a wide range of industrial applications. PFHxS and perfluorooctane sulfonate are able to accumulate in the environment and in humans with the approximated serum elimination half-life in the range of several years. More recently, some PFAS compounds have also been suggested as potential immunosuppressants. In this study, we analyze immune cell numbers in mice following 28-d repeated oral exposure to potassium PFHxS at 12, 120, 1,200, and 12,000 ng/kg/d, with resulting serum levels ranging up to ∼1,600 ng/ml, approximating ranges found in the general population and at higher levels in PFAS workers. The immunosuppressant cyclophosphamide was analyzed as a positive control. B cells, T cells, and granulocytes from the bone marrow, liver, spleen, lymph nodes, and thymus were evaluated. We found that at these exposures, there was no effect of PFHxS on major T or B cell populations, macrophages, dendritic cells, basophils, mast cells, eosinophils, neutrophils, or circulating Ab isotypes. By contrast, mice exposed to cyclophosphamide exhibited depletion of several granulocyte and T and B cell populations in the thymus, bone marrow, and spleen, as well as reductions in IgG1, IgG2b, IgG2c, IgG3, IgE, and IgM. These data indicate that exposures of up to 12,000 ng/kg of PFHxS for 28 d do not affect immune cell numbers in naive mice, which provides valuable information for assessing the risks and health influences of exposures to this compound.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology & Immunology, Cornell University, Ithaca, NY.
- 3M Company, St. Paul, MN.
ORCID-Profile: Jessica Elmore, Orchi Anannya, Katelyn O'Hare, Alanis Villanueva, Sasha Anronikov, Narda Bondah, Sue Chang, Julie Sahler, Avery August
Zitieren
APA
Pierpont, T. M., Elmore, J., Redko, A., Anannya, O., Imbiakha, B., O'Hare, K., Villanueva, A., Anronikov, S., Bondah, N., Chang, S., Sahler, J., & August, A. (2024). Effects of Perfluorohexane Sulfonate Exposure on Immune Cell Populations in Naive Mice. ImmunoHorizons. https://doi.org/10.4049/immunohorizons.2300049
Vancouver
Pierpont TM, Elmore J, Redko A, Anannya O, Imbiakha B, O'Hare K, et al. Effects of Perfluorohexane Sulfonate Exposure on Immune Cell Populations in Naive Mice. ImmunoHorizons. 2024. doi:10.4049/immunohorizons.2300049
BibTeX
@article{Pierpont2024,
author = {Pierpont, Timothy M and Elmore, Jessica and Redko, Amie and Anannya, Orchi and Imbiakha, Brian and O'Hare, Katelyn and Villanueva, Alanis and Anronikov, Sasha and Bondah, Narda and Chang, Sue and Sahler, Julie and August, Avery},
title = {Effects of Perfluorohexane Sulfonate Exposure on Immune Cell Populations in Naive Mice},
journal = {ImmunoHorizons},
year = {2024},
doi = {10.4049/immunohorizons.2300049}
}
EUVIMED